ACADIA HEALTHCARE CO INC (ACHC)
US00404A1097 - Common Stock
Taking everything into account, ACHC scores 4 out of 10 in our fundamental rating. ACHC was compared to 113 industry peers in the Health Care Providers & Services industry. ACHC has a medium profitability rating, but doesn't score so well on its financial health evaluation. ACHC is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
ACHC had positive earnings in the past year.
In the past year ACHC had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ACHC reported negative net income in multiple years.
Each year in the past 5 years ACHC had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 4.78%, ACHC is doing good in the industry, outperforming 79.65% of the companies in the same industry.
With a decent Return On Equity value of 9.26%, ACHC is doing good in the industry, outperforming 74.34% of the companies in the same industry.
ACHC has a Return On Invested Capital of 7.74%. This is in the better half of the industry: ACHC outperforms 79.65% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ACHC is in line with the industry average of 8.01%.
The 3 year average ROIC (7.51%) for ACHC is below the current ROIC(7.74%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.78% | ||
| ROE | 9.26% | ||
| ROIC | 7.74% |
ROA(3y)3.02%
ROA(5y)0.06%
ROE(3y)5.5%
ROE(5y)-2.91%
ROIC(3y)7.51%
ROIC(5y)6.2%
1.3 Margins
The Profit Margin of ACHC (8.99%) is better than 92.92% of its industry peers.
The Operating Margin of ACHC (17.42%) is better than 98.23% of its industry peers.
In the last couple of years the Operating Margin of ACHC has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.42% | ||
| PM (TTM) | 8.99% | ||
| GM | N/A |
OM growth 3Y2.8%
OM growth 5Y1.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ACHC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ACHC has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ACHC has more shares outstanding
The debt/assets ratio for ACHC has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.76, we must say that ACHC is in the distress zone and has some risk of bankruptcy.
ACHC's Altman-Z score of 1.76 is in line compared to the rest of the industry. ACHC outperforms 52.21% of its industry peers.
ACHC has a Debt/Equity ratio of 0.60. This is a neutral value indicating ACHC is somewhat dependend on debt financing.
ACHC has a Debt to Equity ratio (0.60) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.76 |
ROIC/WACC0.99
WACC7.79%
2.3 Liquidity
ACHC has a Current Ratio of 1.07. This is a normal value and indicates that ACHC is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.07, ACHC is not doing good in the industry: 72.57% of the companies in the same industry are doing better.
A Quick Ratio of 1.06 indicates that ACHC should not have too much problems paying its short term obligations.
ACHC's Quick ratio of 1.06 is on the low side compared to the rest of the industry. ACHC is outperformed by 65.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.07 | ||
| Quick Ratio | 1.06 |
3. Growth
3.1 Past
ACHC shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.01%.
Measured over the past years, ACHC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.90% on average per year.
Looking at the last year, ACHC shows a quite strong growth in Revenue. The Revenue has grown by 9.13% in the last year.
Measured over the past years, ACHC shows a quite strong growth in Revenue. The Revenue has been growing by 8.99% on average per year.
EPS 1Y (TTM)7.01%
EPS 3Y7.38%
EPS 5Y8.9%
EPS Q2Q%0%
Revenue 1Y (TTM)9.13%
Revenue growth 3Y11.91%
Revenue growth 5Y8.99%
Sales Q2Q%8.7%
3.2 Future
The Earnings Per Share is expected to grow by 13.50% on average over the next years. This is quite good.
ACHC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.74% yearly.
EPS Next Y4.41%
EPS Next 2Y8.14%
EPS Next 3Y10.12%
EPS Next 5Y13.5%
Revenue Next Year9.99%
Revenue Next 2Y10.11%
Revenue Next 3Y10.2%
Revenue Next 5Y10.74%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 12.06, which indicates a correct valuation of ACHC.
Based on the Price/Earnings ratio, ACHC is valued cheaply inside the industry as 88.50% of the companies are valued more expensively.
ACHC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 30.20.
With a Price/Forward Earnings ratio of 10.55, the valuation of ACHC can be described as very reasonable.
Based on the Price/Forward Earnings ratio, ACHC is valued cheaper than 91.15% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ACHC to the average of the S&P500 Index (23.28), we can say ACHC is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.06 | ||
| Fwd PE | 10.55 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ACHC is valued cheaply inside the industry as 86.73% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 8.27 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ACHC does not grow enough to justify the current Price/Earnings ratio.
ACHC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.73
PEG (5Y)1.36
EPS Next 2Y8.14%
EPS Next 3Y10.12%
5. Dividend
5.1 Amount
No dividends for ACHC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ACADIA HEALTHCARE CO INC
NASDAQ:ACHC (11/4/2024, 8:00:00 PM)
After market: 42.33 0 (0%)42.33
+0.31 (+0.74%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.93B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.06 | ||
| Fwd PE | 10.55 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.73
PEG (5Y)1.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.78% | ||
| ROE | 9.26% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 17.42% | ||
| PM (TTM) | 8.99% | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.07 | ||
| Quick Ratio | 1.06 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)7.01%
EPS 3Y7.38%
EPS 5Y
EPS Q2Q%
EPS Next Y4.41%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)9.13%
Revenue growth 3Y11.91%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y